TrialThe Journal of infectious diseases2015

AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.

Pope Kosalaraksa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.